Related by context. All words. (Click for frequent words.) 87 accumulate preferentially 78 liposomal formulation 77 chimeric monoclonal antibody 76 humanized monoclonal 76 investigational humanized monoclonal antibody 76 targeted radiotherapeutic 76 Alfacell proprietary ribonuclease 76 novel peptide 76 vinorelbine tartrate 76 humanized antibody 75 SPL# Gel vaginal microbicide 75 proteasome inhibitor 75 biomodulator 75 mertansine 75 somatostatin analogue 74 HSP# inhibitor 74 TLR9 agonist 74 peptibody 74 histone deacetylase inhibitor 74 HepDirect prodrug 74 Pralatrexate 74 anti CD3 74 targeting CD# 74 dasatinib Sprycel 74 microtubule inhibitor 73 Liposomal 73 novel histone deacetylase 73 thalidomide Thalomid 73 vinca alkaloid 73 IgG1 monoclonal antibody 73 IAP inhibitor 73 erlotinib Tarceva ® 73 Personalized Immunotherapy 73 humanized anti 73 taxane derivative 73 Fc fusion protein 73 PI3K/Akt pathway inhibitor 73 bevacizumab Avastin R 73 candidate deforolimus 73 Degarelix 73 lexidronam injection 73 orally administered inhibitor 73 pan HDAC inhibitor 72 vapreotide acetate 72 cetuximab Erbitux R 72 ADP receptor antagonist 72 DiLA2 72 Preclinical studies suggest 72 HuMax 72 intranasal formulation 72 nucleoside analog 72 carbohydrate polymer 72 small molecule tyrosine 72 KSP inhibitor 72 depsipeptide 72 AAG geldanamycin analog 72 Pathway Inhibitor 72 monoclonal antibody IgG1 Mab 72 Anticalins R 72 Radiation Therapy SIRT 72 small molecule glucokinase 72 hormone LHRH antagonist 72 DNA intercalator 72 Zorbtive TM 72 hyaluronidase enzyme 72 MAGE A3 ASCI 72 Factor VIIa 72 topically applied SEPA 72 Micromet BiTE 72 mTOR mammalian target 72 multi kinase inhibitor 72 Orally administered 72 investigational immunotherapy 72 selective kinase inhibitor 72 receptor tyrosine kinase inhibitor 72 Imatinib mesylate 72 treat chronic sinusitis 72 investigational monoclonal antibody 72 proprietary polysaccharide 71 estrogen receptor antagonist 71 tubulin binding 71 selectively inhibited 71 reslizumab 71 targets Galectin receptors 71 Angiotensin Converting Enzyme 71 MTP inhibitor 71 radiotherapeutic 71 potent cytotoxic 71 orally dosed 71 selective inhibition 71 PORxin TM 71 histone deacetylase HDAC inhibitor 71 polyclonal antibody 71 metastatic malignant 71 immune modulating 71 SinuNase ™ 71 antibody MAb 71 Squalamine 71 Pertuzumab 71 platform HDL Mimetic 71 PDE4 inhibitor 71 M2 subunit 71 Monoclonal antibody 71 Luteinizing Hormone Releasing Hormone 71 adult mesenchymal stem 71 small molecule chemotherapeutic 71 SGLT2 inhibitors 71 erlotinib Tarceva R 71 etanercept Enbrel 71 therapeutic monoclonal antibody 71 imatinib Gleevec ® 71 allogeneic cell 71 non porcine pancreatic 71 selectively inhibit 71 histamine dihydrochloride 71 polysaccharide polymer 71 PKC# 71 immunotherapeutic agent 71 IMiDs R 71 Factor Receptor 71 bispecific 71 PNP inhibitor 71 pan histone deacetylase 71 autologous cellular immunotherapy 71 Transdrug ® nanoparticle 71 Vidaza azacitidine 71 personalized dendritic 71 M# rationally 71 rxRNA 71 cutaneous T 71 humanised monoclonal antibody 71 histone deacetylase HDAC 71 liposomal delivery 71 Panzem NCD 71 Immunotherapeutic 71 inhibitor PPI 71 inhibit VEGF 71 tyrosine kinase inhibitor 71 selective antagonist 71 peripherally acting 71 dasatinib Sprycel ® 71 vascular disrupting agents 71 intravesical instillation 71 denileukin diftitox 71 Bosutinib 71 PEGylated Fab fragment 71 sorafenib Nexavar 71 pregabalin Lyrica 70 nilotinib Tasigna 70 docetaxel Taxotere ® 70 peptidomimetic 70 IL# PE#QQR 70 YONDELIS 70 Panzem R 70 Cyclosert TM 70 cathepsin K inhibitor 70 Interferon beta 70 humanized therapeutic 70 histone deacetylase HDAC inhibitors 70 Enkephalin 70 NeoLipid TM 70 Myolimus 70 anticancer compound 70 TLK# 70 selective modulator 70 essential thrombocythemia ET 70 peptidic compound 70 paclitaxel Taxol ® 70 MKC# MKC# PP 70 GVAX ® 70 immune modulatory 70 Janus Kinase 70 kidney urologic 70 Levoleucovorin 70 luteinizing hormone releasing 70 Liprotamase 70 ZFP TF 70 lutropin alfa 70 non nucleoside inhibitor 70 Cx# [002] 70 ibritumomab tiuxetan 70 HuLuc# 70 Kahalalide F 70 hypereosinophilic syndrome 70 R Saizen R 70 PDX pralatrexate 70 SMARTICLES ® 70 acetonide FA 70 Elotuzumab 70 poly ADP ribose polymerase 70 Calcitonin 70 uricase 70 sunitinib Sutent ® 70 Omacetaxine 70 paclitaxel Taxol 70 JAK2 inhibitor 70 prodrugs 70 VitiGam 70 Gonal f R 70 cyclin dependent kinase inhibitor 70 Kinase Inhibitor 70 enzyme inhibitor 70 alkylating 70 Ataluren 70 Locked Nucleic Acid LNA 70 HuCNS SC ® 70 oral prodrug 70 selective orally bioavailable 70 novel prodrug 70 liposome encapsulated 70 sodium glucose cotransporter 70 2 methoxyestradiol 70 protein tyrosine phosphatase 1B 70 ATRA IV 70 Initiates Enrollment 70 molecular imaging radiopharmaceutical 70 Anticalins ® 70 humanized monoclonal antibodies 70 Myocet 70 Fludara ® 70 inhibit oxidative stress 70 potent antiproliferative 70 oncolytic virus therapies 70 Panzem R NCD 70 Interferon alfa 70 antimitotic 70 Xanafide 70 Elvitegravir 70 CYT# potent vascular disrupting 70 adenosine A2A 70 Granulocyte Colony Stimulating Factor 70 generation purine nucleoside 70 5 HT3 antagonist 70 hypervascular tumors 70 ZOLINZA 70 PEGylated interferon 70 drug zotarolimus 70 treat lupus renal 70 immunomodulator 70 Gleevec resistant 70 MP4 molecule 70 Romidepsin 70 Protein Kinase C 70 orally bioavailable 70 cortisol synthesis 70 liposomal doxorubicin 70 TNF Tumor Necrosis Factor 70 using Innocoll proprietary 69 Vascugel 69 acadesine 69 inhaled formulation 69 Initiate Clinical Trial 69 Camptosar ® 69 small molecule Hedgehog 69 anti CD3 antibody 69 ZEVALIN ® 69 Upregulation 69 GW# [003] 69 Blinatumomab 69 Zysolin TM 69 humanized monoclonal antibody 69 angiogenesis inhibitor 69 pancreatic enzyme replacement 69 acid phosphatase PAP 69 ENMD # 69 NeoLipid R 69 IMA# 69 lipid nanoparticle 69 PEGylated 69 novel emulsion formulation 69 anti angiogenic agent 69 bevacizumab Avastin ® 69 Transdrug R 69 protein kinase inhibitor 69 XTEN 69 PI3K/mTOR 69 IgG1 antibody 69 pharmacologically active isomer 69 MGd 69 Initiates Phase II 69 isoform selective 69 topical gel formulation 69 Aurora Kinase 69 Traficet EN 69 potent topoisomerase II 69 docetaxel Taxotere R 69 HyperAcute 69 gemcitabine Gemzar 69 Romiplostim 69 Clolar ® 69 RAF kinase 69 HQK 69 modified glutathione analog 69 selective adenosine 69 Homspera TM 69 AKT inhibitor 69 mitogen activated ERK kinase 69 Etoposide 69 rhIGF-I/rhIGFBP-3 69 Peginterferon alfa 2b 69 Litx 69 synthetic peptide 69 NPC 1C 69 Onconase 69 factor G CSF 69 tumor vascular disrupting 69 Camptosar ® irinotecan 69 LHRH receptor positive 69 prostanoid 69 Receives Orphan Drug Designation 69 gefitinib Iressa 69 Cloretazine 69 platinum chemotherapeutic 69 selective immunoproteasome inhibitor 69 MKC# MT 69 PROfusion 69 GMX# 69 hypoxia activated prodrug 69 rituximab Rituxan 69 cyclic peptide 69 NeuroSTAT ® 69 Aflibercept 69 Sandimmune 69 Hsp# Inhibitor 69 antifibrotic 69 triggers apoptosis programmed 69 vorinostat 69 Gonal f ® 69 highly selective inhibitor 69 Tyrosine Kinase Inhibitor 69 GRNVAC1 69 immune modulator 69 busulfan 69 5 HT4 69 XL# XL# 69 Epidermal Growth Factor Receptor 69 enhance ApoA 69 Leukine ® 69 sargramostim 69 5 HT2A serotonin 69 engineered anticoagulant 69 imatinib Gleevec 69 Pazopanib 69 5 fluorouracil leucovorin 69 bortezomib Velcade 69 beta 1a 69 potent inducer 69 small molecule thrombopoietin 69 ErbB1 69 BiTE R 69 tyrosine kinase inhibitor TKI 69 THR beta agonist 69 RNA antagonist 69 nucleotide analog 69 RNAi therapeutic targeting 69 monoclonal antibody mAb 69 effector function 69 Annamycin 69 poly ethylene glycol PEG 69 CYP#A# CYP#D# 69 Denufosol 69 demethylating agent 69 PrevOnco 69 Interferon alpha 69 IAP inhibitors 69 recombinant adeno associated 69 nanopharmaceutical 69 proteasome inhibitors 69 PI3K inhibitor 69 Opterone R 69 Inhalation Solution 69 bispecific antibodies 69 Aviptadil 69 Mesenchymal 69 Bicalutamide 69 KL4 Surfactant 69 Nipent R 69 synthetic peptide containing 69 drug conjugate 69 DUROS 69 Bezielle 69 selective agonist 69 DCVax R 68 cetuximab Erbitux ® 68 Soliris eculizumab 68 humanised antibody 68 Antiangiogenic 68 bifunctional 68 Cyclosert 68 Intravenous Human 68 bioresorbable polymer 68 gamma secretase inhibitor 68 Phase #b/#a clinical 68 5 Fluorouracil 68 oral beclomethasone dipropionate 68 soluble tumor necrosis 68 Bendamustine 68 HDAC Inhibitor 68 siRNA binds 68 epothilones 68 mda 7 68 Presents Preclinical Data 68 refractory chronic lymphocytic 68 personalized cellular immunotherapy 68 Neupogen ® 68 alkylating agent 68 candidates Azedra TM 68 Maribavir 68 volociximab 68 IV Busulfex 68 sublingual formulation 68 COX Inhibiting Nitric Oxide 68 anti secretory 68 Doripenem 68 adalimumab Humira 68 levoleucovorin 68 Pemetrexed 68 Temsirolimus 68 Angiocept 68 VNP#M 68 potently inhibit 68 anionic backbone 68 POTELLIGENT ® 68 murine monoclonal antibody 68 Factor Xa inhibitor 68 Transdermal Patch 68 novel synthetic peptide 68 orally inhaled 68 treat male hypogonadism 68 demonstrated antitumor activity 68 Pharmacokinetics PK 68 Methylnaltrexone 68 topical ophthalmic 68 Clofarabine 68 antiproliferative effects 68 MyoCell TM 68 antiangiogenic agent 68 TOCOSOL 68 hereditary emphysema 68 candidate TNFerade biologic 68 BrachySil TM 68 Hematopoietic 68 VALSTAR 68 metaglidasen 68 Zarnestra 68 Known generically 68 virus AAV 68 dendritic cell vaccine 68 Initiates Clinical 68 IMiDs ® compound 68 agonistic human 68 directed radiotherapeutic antibody 68 Tesetaxel 68 verteporfin 68 lipoglycopeptide 68 oxazolidinone 68 dihydrochloride 68 CDK inhibitor 68 corticosteroid dexamethasone 68 non peptidic protease 68 Irinotecan 68 OXIGON 68 Dalbavancin 68 AFREZZA TM 68 Chemokine Receptor 68 cisplatin resistant 68 intravenously administered 68 Lubiprostone 68 Alferon N 68 MT#/MEDI-# 68 mTOR inhibitors 68 biologic antibody 68 Cethrin R 68 chronic eosinophilic leukemia 68 hypoxia inducible factor 68 Enhanze TM Technology 68 Quinamed 68 Locked Nucleic Acid 68 PEGylated anti 68 Xcellerated T Cells 68 Sphingomab TM 68 recombinant subunit vaccine 68 Recombinant Human 68 Cyclosporin 68 HepaGam B 68 ONCASPAR 68 NanoTab 68 PDE4 68 HDL Mimetic Peptide 68 apomorphine hydrochloride 68 juvenile chondrocytes 68 systemic immunosuppressive drugs 68 evaluating satraplatin 68 alefacept 68 Anidulafungin 68 Cytoxan ® 68 Aplidin R 68 Prolastin A1PI 68 novel topoisomerase 68 GRNOPC1 contains 68 Gemzar gemcitabine 68 carmustine 68 hPTH #-# 68 albumin bound paclitaxel 68 Ecallantide 68 Cathepsin S 68 Bazedoxifene 68 Selective Internal 68 anti CD3 monoclonal 68 selective estrogen receptor modulator 68 mTOR inhibitor 68 sd rxRNA 68 urethral bulking agent 68 IMiDs ® 68 Hemospan 68 androgen receptor antagonist 68 murine model 68 Thiarabine 68 LHRH antagonist 68 Xyfid TM 68 HuMax TAC 68 JAK1 68 selective inhibitor 68 Taxol ® 68 MOVIPREP R 68 Replacement Therapy 68 irreversible inhibitor 68 radiation sensitizer 68 inhalation powder 68 novel oral anticoagulant 68 Crofelemer budesonide foam 68 Anti VEGF 68 selective serotonin 2C receptor 68 mu opioid receptor antagonist 68 bispecific antibody 68 pentostatin 68 EnteroMedics proprietary neuroblocking technology 68 inhibit angiogenesis 68 Neulasta ® 68 Talabostat 68 induces apoptosis 68 Neulasta R 68 siRNA therapeutic 68 OncoGel 68 TÎ ² 4 68 Saizen R 68 Taxanes 68 subcutaneously administered 68 novel VDA molecule 68 intravesical infusion therapy 68 herpes simplex viruses 68 HDL Selective Delipidation 68 OncoVex 68 investigational pharmacologically unique 68 anti CD# monoclonal 68 long acting muscarinic 68 Tarceva TM 68 FUSILEV enhances 68 poloxamer 68 trastuzumab Herceptin 68 PDGF receptor 68 Dapagliflozin 68 Janus kinase 68 liposomal 68 brivanib 68 rxRNA ™ compounds 68 thrombin receptor 67 Triapine 67 Sudhir Agrawal D.Phil 67 Meets Primary Endpoint 67 Antigen Specific 67 oral Janus kinase 67 iobenguane 67 plasmid encoding 67 Tiuxetan 67 entinostat 67 Aliskiren 67 peptide conjugated 67 Deforolimus 67 Pruvel TM 67 alpha folate receptor 67 PSMA ADC 67 reversible inhibitor 67 Ovitrelle R Serostim 67 bucindolol hydrochloride 67 immunoconjugate 67 rALLy clinical trial 67 Archexin 67 NTDDS 67 rivastigmine Exelon 67 herpetic keratitis 67 antimetabolite 67 LEUKINE 67 acyclovir Lauriad R 67 prostate cancer antigen prostatic 67 BiTE ® 67 prescribed proton pump 67 plasmid DNA pDNA 67 ® bortezomib 67 hormone agonist 67 fosbretabulin 67 octreotide acetate 67 RECOTHROM R 67 Allogeneic 67 panitumumab Vectibix R 67 Cytotoxic 67 antitumoral 67 Nexavar ® 67 Photodynamic therapy PDT 67 Lenalidomide 67 HSP# inhibitors 67 Enzastaurin 67 Vidaza ® 67 DOS# 67 Bruton tyrosine kinase 67 Anti angiogenic 67 Ganciclovir 67 lidocaine hydrochloride monohydrate powder 67 Piperacillin 67 Fluconazole 67 vidofludimus 67 apoptosis proteins 67 Vandetanib 67 interleukin IL -# 67 Acellular 67 oral anti arrhythmic 67 Completes Patient Enrollment 67 Microspheres 67 samarium Sm 67 Paraplatin ® 67 Calando proprietary 67 Sipuleucel T 67 lipopeptides 67 Campath alemtuzumab 67 cytotoxic T lymphocyte 67 cytoprotective 67 immunostimulatory 67 thymosin beta 4 67 A1PI 67 monoclonal antibody MAb 67 Enhanze Technology 67 Valtropin 67 oral picoplatin 67 Biolimus A9 67 patented Bioral 67 DURIN TM 67 syngeneic 67 investigational integrase inhibitor 67 novel immunomodulatory 67 opioid receptor antagonist 67 OncoVEX 67 Dasatinib 67 siRNAs targeting 67 DNA demethylating agent 67 cyclophosphamide methotrexate 67 Saforis 67 human IgG1 monoclonal 67 Vidaza R 67 stable nucleic acid 67 pegylated liposomal doxorubicin 67 specific lectin receptors 67 PrevOnco ™ 67 OMNARIS HFA 67 fludarabine phosphate 67 situ gelling 67 Nexavar sorafenib tablets 67 anticancer therapeutics 67 small molecule activators 67 Initiates Clinical Trial 67 Xeloda ® 67 thymidylate synthase TS 67 investigational antibody 67 meropenem 67 highly selective endothelin 67 CEQ# 67 Xencor XmAb 67 fluoropyrimidine 67 Olaparib 67 Cloretazine VNP#M 67 Silodosin 67 Demonstrates Potential 67 metastatic colorectal 67 ISF# 67 TO AVOID PREGNANCY WHILE 67 Fleximer 67 BiTE 67 TAFA# 67 Trastuzumab DM1 67 antibody fragment 67 chemotherapy FOLFOX 67 diarrhea predominant irritable 67 TKB# 67 TG# [003] 67 colony stimulating factor 67 ligand TRAIL 67 coronary stent merged 67 Onalta ™ 67 xanthine oxidase inhibitor 67 Files IND 67 Generx TM 67 INSPIRE Trial Phase III 67 Granted Orphan Drug 67 thetreatment 67 PARI Pharma GmbH 67 Diabetic Neuropathy 67 PSN# [001] 67 antisense inhibitor 67 Curaxin CBLC# 67 TRX1 67 p# inhibitor 67 sodium thiosulfate STS 67 novel immunotherapeutic 67 PEG SN# 67 VISICOL R 67 Pramlintide 67 Erlotinib 67 rHuPH# recombinant human 67 Genotyping Test 67 TELINTRA 67 antiapoptotic 67 Anavex #-# 67 cromolyn sodium 67 immunotoxin 67 Sapacitabine 67 topoisomerase II inhibitor 67 monoclonal antibody conjugated 67 protein mTOR 67 synthetic siRNA 67 Belerofon 67 MEK inhibitor 67 tumor xenograft models 67 SPRYCEL ® 67 SinuNase TM 67 YONDELIS R 67 oral talactoferrin 67 Corgentin 67 Prodarsan R 67 tiuxetan 67 Pentad TM 67 HCV protease inhibitors 67 modulator SERM 67 histone deacetylase 67 malignant ascites 67 RhuDex ® 67 telomerase therapeutic 67 Rituxan rituximab 67 Indibulin ZIO 67 Evoltra ® 67 CCR5 antagonist 67 purified recombinant 67 advanced metastatic renal 67 Azacitidine 67 oral antiviral 67 cilengitide 67 Presents Preclinical 67 selective phosphodiesterase 67 Iluvien TM 67 antibiofilm 67 R lenalidomide 67 methylnaltrexone bromide 67 QUADRAMET R 67 Tyrima 67 potent anticancer 67 MyVax R 67 pain palliation 67 echinocandin 67 immunomodulating 67 evaluating tivozanib 67 Anticalin ® 67 allogeneic epidermal 67 oral Hsp# inhibitor 67 ALK inhibitor 67 cellular immunotherapy 67 Novel Oral 67 dextromethorphan quinidine 67 non nucleoside 67 QuadraSphere 67 virus HCV protease inhibitor 67 CD4 monoclonal antibody 67 trabectedin 67 chemotherapeutic drug 67 Ixabepilone 67 superparamagnetic iron oxide nanoparticles 67 BAY #-# 67 Myelodysplastic Syndrome MDS 67 Decitabine 67 signal transduction inhibitor 67 bleomycin 67 Carfilzomib 67 cisplatin carboplatin 67 glycopeptides 67 oligodendrocyte progenitor cells 67 anti infective treatments 67 Lenocta 67 oxidative stress inducer 67 lipopeptide 67 developing TB4 67 CYC# 67 Cytarabine 67 Solazed TM 67 Vascular Wrap TM 67 Kit CD# positive 67 PGL# 67 HCV RNA polymerase 67 Antigenics QS 67 Voreloxin 67 HuMax CD4 67 Vaprisol 67 multitargeted 67 Tumor necrosis factor 67 Gastrointestinal Liner 67 Trofex 67 ImmunoBody ® 67 MET VEGFR2 67 itraconazole Sporanox 67 dipeptidyl peptidase IV 67 LymphoStat B TM 67 Tumor Necrosis Factor 67 diagnostic biomarker 67 XP# XP# 67 Inhaled nitric oxide 67 delivers fluocinolone acetonide FA 67 VitiGam TM 67 nasal spray formulation 67 Taxotere docetaxel 67 recombinant fusion 67 Fibroblast Growth Factor 67 OvaRex R 67 Tarmogen 67 huC# DM4 66 antiarrhythmic agent 66 geldanamycin 66 gemcitabine cisplatin 66 5 FU leucovorin 66 Trastuzumab 66 oral immunomodulatory 66 Abatacept 66 Tumour Vascular Disrupting Agent 66 recombinant antibodies 66 Amplimexon 66 cidofovir 66 sorafenib tablets 66 cisplatin gemcitabine 66 Fenretinide 66 HCD# [002] 66 R bendamustine hydrochloride 66 Intravesical 66 Vaxfectin TM adjuvant 66 Aplidin 66 Lymphoid 66 PTH analogue 66 FS Antihemophilic Factor Recombinant 66 lenalidomide Revlimid R 66 covalently bound 66 Pyridorin 66 Vinorelbine 66 ARRY # 66 Guanilib 66 Serostim ® 66 osteogenic 66 Stromal 66 4 PDE4 enzyme 66 topically administered 66 Familial Adenomatous Polyposis FAP 66 AEG# 66 NSCLC tumors 66 Ceflatonin 66 Mg Usa 66 Resten NG 66 vinblastine 66 vivo validation 66 Everolimus 66 indinavir Crixivan 66 oxaliplatin Eloxatin 66 vinca alkaloids 66 Cotara ® 66 leukemia AML 66 erlotinib Tarceva 66 apoptosis inducers 66 Prostacyclin 66 oncolytic 66 Abbokinase 66 retinoic acid receptor 66 Oral NKTR 66 cytostatic 66 unresectable inoperable 66 HepaMate 66 monoclonal 66 Achieves Primary Endpoint 66 Melphalan 66 TRAIL R2 66 HER1 66 Oral Mucositis 66 orally bioavailable mimics 66 Collategene 66 xenograft 66 Indomethacin 66 TRO# 66 Aptamer 66 Apoptone HE# 66 immunoregulatory 66 Enzyme Replacement Therapy 66 CD# monoclonal antibody 66 DermaVir Patch 66 gastrointestinal stromal tumors GIST 66 Marqibo TM 66 kinesin spindle protein 66 Aganocide 66 myelodysplastic myeloproliferative diseases 66 chemokine receptor 66 multicenter Phase II 66 polyglutamate 66 osteoconductive 66 immunomodulatory properties 66 cationic lipid 66 Foradil Aerolizer 66 ABL inhibitor 66 Mg Uk 66 BrachySil ™ 66 Platelet Derived Growth 66 cell lymphoma CTCL 66 anti EGFR antibody 66 antisense inhibitors 66 REPRONEX R menotropins 66 Boniva ibandronate 66 ActA 66 Nilotinib 66 Interferon Alpha 66 antisense oligonucleotide 66 Parathyroid Hormone 66 Electronic Brachytherapy System 66 Eculizumab 66 oral dihydropyrimidine dehydrogenase DPD 66 CD8 + cytotoxic 66 demethylating agents 66 inhibit vascular endothelial 66 docetaxel Taxotere 66 dermal patch 66 Lixivaptan 66 ® lenalidomide 66 PF # [002] 66 oral Factor Xa 66 ASG 5ME 66 MAb 66 triphendiol 66 Hycamtin ® 66 BN# [002] 66 treating abdominal aortic 66 Doxorubicin 66 HGS ETR1 mapatumumab 66 DP VPA 66 Gefitinib 66 Submits NDA 66 calcitonin gene related 66 BCG refractory carcinoma 66 anti atherothrombotic 66 Cetuximab Erbitux 66 CG# [003] 66 chemically modified siRNA 66 folate analogue metabolic 66 potently inhibited 66 NAVISTAR R 66 lead molecular radiotherapeutic 66 R sorafenib tablets 66 cyclin dependent kinase CDK 66 Etravirine 66 dihydrofolate reductase 66 Azedra 66 vaccines oncolytic virus 66 protein tyrosine 66 EGFR TKIs 66 ABLYNX 66 HDACi 66 Systemic Delivery 66 purine analog 66 novel antifolate 66 Mepact 66 mediated inhibition 66 adipose tissue derived 66 INCB# [001] 66 SYN# 66 JAK inhibitor 66 monoclonal anti 66 Junovan TM 66 Mycophenolate Mofetil 66 tumor specific antigen 66 Bucindolol 66 muscarinic antagonist 66 CTAP# Capsules 66 Alocrest 66 Ridaforolimus 66 BAL# [002] 66 intranasal delivery 66 Fibroblast Growth Factor Receptor 66 NP2 66 trastuzumab Herceptin R 66 Solzira ™ 66 Darinaparsin 66 delta gamma agonist